S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 61 to 120 of 197

Issue Date	Title / Author(s) / Citation	File
2009-12	Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy Park, Chul-Kee; Lee, Se-Hoon; Han, Jung Ho; Kim, Chae-Yong; Kim, Dong-Wan; Paek, Sun Ha; Kim, Dong Gyu; Heo, Dae Seog; Kim, Il Han; Jung, Hee-Won BMC Cancer, Vol.9, p. 450	view file DOI
2010	Predictive and prognostic role of class Ⅲ β-tubulin and ERCC1 expression in locally advanced head and neck squamous cell carcinoma 고영일	link
2010	Macrophage migration inhibitory factor (MIF) increases migration potential of gastric cancer cell lines via induction of CXCR2 expression 장미니	link
2010-02	Conditionally replicating adenovirus improves gene replication efficiency and anticancer effect of E1-deleted adenovirus carrying TRAIL in head and neck squamous cell carcinoma Shim, Seon-Hui; Lee, Choon-Taek; Hah, J. Hun; Lee, Jae-Jung; Heo, Dae Seog; Sung, Myung-Whun; Park, Seok-Woo CANCER SCIENCE; Vol.101 2; 482-487	DOI
2010-04	Dexamethasone treatment inhibits VEGF production via suppression of STAT3 in a head and neck cancer cell line Shim, Seon-Hui; Hah, J. Hun; Hwang, So-Yeon; Heo, Dae Seog; Sung, Myung-Whun ONCOLOGY REPORTS; Vol.23 4; 1139-1143	DOI
2010-05	First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective analysis of clinical predictors Kim, Tae Min; Kim, Ki Hwan; Lee, Min Joung; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Chul Woo; Kim, Il Han; Khwarg, Sang In; Heo, Dae Seog Cancer Science, Vol.101 No.5, pp.1199-1203	view file DOI
2010-06	Impact of caregivers' unmet needs for supportive care on quality of terminal cancer care delivered and caregiver's workforce performance Park, Sang Min; Kim, Young Jin; Kim, Samyong; Choi, Jong Soo; Lim, Ho-Yeong; Choi, Youn Seon; Hong, Young Seon; Kim, Si-Young; Heo, Dae Seog; Kang, Ki Moon; Jeong, Hyun Sik; Lee, Chang Geol; Moon, Do Ho; Choi, Jin-Young; Kong, In Sik; Yun, Young Ho SUPPORTIVE CARE IN CANCER Vol.18 No.6, pp. 699-706	DOI
2010-06	Definitive Radiotherapy With or Without Chemotherapy for T3-4N0 Squamous Cell Carcinoma of the Maxillary Sinus and Nasal Cavity Jang, Na Young; Wu, Hong-Gyun; Park, Charn Il; Heo, Dae-Seog; Kim, Dong-Wan; Lee, Se-Hoon; Rhee, Chae-Seo Japanese Journal of Clinical Oncology, Vol.40 No.6, pp.542-548	DOI
2010-11	DIFFERENTIAL EFFECTS BETWEEN CYCLOOXYGENASE-2 INHIBITORS AND siRNA ON VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION IN HEAD AND NECK SQUAMOUS CELL CARCINOMA CELL LINES Park, Seok-Woo; Kim, Hyo-Sun; Hah, Jeong-Hun; Kim, Kwang-Hyun; Sung, Myung-Whun; Heo, Dae-Seog HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK; Vol.32 11; 1534-1543	DOI
2010-12	A combination treatment with SAHA and ad-p63/p73 shows an enhanced anticancer effect in HNSCC Shim, Seon-Hui; Lee, Choon-Taek; Lee, Jae-Jung; Kim, So-Yeon; Heo, Dae Seog; Sung, Myung-Whun; Hah, J. Hun TUMOR BIOLOGY; Vol.31 6; 659-666	DOI
2011-01	A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinonna harboring EGFR mutations Kim, Dong-Wan; Lee, Se-Hoon; Lee, Jong Seok; Lee, Myung Ah; Kang, Jin Hyoung; Kim, Si Young; Shin, Sang Won; Kim, Hoon-Kyo; Heo, Dae Seog Lung Cancer, Vol.71 No.1, pp.65-69	DOI
2011-02	Molecular marker analysis of effectiveness in patients with stage II/III breast cancer treated with paclitaxel/gemcitabine-based neoadjuvant chemotherapy 이근석	link
2011-04	EGFR Gene Copy Number Gain is Related to High Tumor SUV and Frequent Relapse after Adjuvant Chemotherapy in Resected Lung Adenocarcinoma Koh, Youngil; Jang, Bogun; Jeon, Yoon Kyung; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Tae; Kim, Young Whan; Heo, Dae Seog Japanese Journal of Clinical Oncology, Vol.41 No.4, pp.548-554	DOI
2011-07	Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial Kim, Il Han; Park, Chul-Kee; Heo, Dae Seog; Kim, Chae-Yong; Rhee, Chang Hun; Nam, Do-Hyun; Lee, Seung Hoon; Han, Jung Ho; Lee, Se-Hoon; Kim, Tae Min; Kim, Dong-Wan; Kim, Jeong Eun; Paek, Sun Ha; Kim, Dong Gyu; Kim, In Ah; Kim, Yu Jung; Kim, Jee Hyun; Park, Byung-Joo; Jung, Hee-Won Journal of Neuro-Oncology, Vol.103 No.3, pp.595-602	DOI
2011-08	(The) property of smaller FOXP1 isoforms in diffuse large B-cell lymphoma 김새롬	link
2011-08	Clinical dissection of multicentric Castleman disease Shin, Dong-Yeop; Jeon, Yoon Kyung; Hong, Yong-Sang; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Inho; Yoon, Sung-Soo; Heo, Dae Seog; Park, Seonyang; Kim, Byoung Kook Leukemia and Lymphoma, Vol.52 No.8, pp.1517-1522	DOI
2011-11	Clinical significance of tumor-infiltrating FOXP3+T cells in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma Kim, Ki Hwan; Kim, Tae Min; Go, Heounjeong; Kim, Wook Youn; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Khwarg, Sang In; Kim, Chul-Woo; Heo, Dae Seog Cancer Science, Vol.102 No.11, pp.1972-1976	view file DOI
2012-02	인간 대장암 세포주에 대한 bortezomib의 억제 효능의 기전에 관한 연구 홍용상	link
2012-02	자연살해세포 백혈병-림프종 세포주에서 gemcitabine 의 항종양 효능 김태민	link
2012-02	Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancer Sim, Sung Hoon; Ahn, Yong-Oon; Yoon, Jieun; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Cancer Science, Vol.103 No.2, pp.155-160	view file DOI
2012-08	Anti-lymphoma activity of lenalidomide against non-germinal center B-cell subtype of diffuse large B-cell lymphoma 차수진	view file
2012-08	Heterogeneity of genetic changes associated with acquired crizotinib resistance in Anaplastic lymphoma kinase-rearranged lung cancer 김소연	view file
2012-08	Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients Park, Heae Surng; Lee, June Koo; Kim, Dong-Wan; Kulig, Kimary; Kim, Tae Min; Lee, Se-Hoon; Jeon, Yoon-Kyung; Chung, Doo Hyun; Heo, Dae Seog Lung Cancer, Vol.77 No.2, pp.288-292	DOI
2012-08	EGFR mutations as a predictive marker of cytotoxic chemotherapy Park, Jin Hyun; Lee, Se-Hoon; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Yang, Seok-Chul; Kim, Young Whan; Heo, Dae Seog Lung Cancer, Vol.77 No.2, pp.433-437	DOI
2012-09	Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis Bae, Hyun-Mi; Lee, Se-Hoon; Kim, Tae Min; Kim, Dong-Wan; Yang, Seok-Chul; Wu, Hong Gyun; Kim, Young Whan; Heo, Dae Seog Lung Cancer, Vol.77 No.3, pp.572-577	DOI
2012-12	Definitive Radiotherapy versus Postoperative Radiotherapy for Tonsil Cancer Koo, Tae Ryool; Wu, Hong-Gyun; Hah, J. Hun; Sung, Myung-Whun; Kim, Kwang-Hyun; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae-Seog; Park, Charn Il Cancer Research and Treatment, Vol.44 No.4, pp.227-234	view file DOI
2012-12	Influence of Comorbidities on the Efficacy of Radiotherapy with or without Chemotherapy in Elderly Stage III Non-small Cell Lung Cancer Patients Lee, Joo Ho; Wu, Hong-Gyun; Kim, Hak Jae; Kim, Dong-Wan; Lee, Se-Hoon; Kim, Tae Min; Kim, Young Whan; Heo, Dae Seog Cancer Research and Treatment, Vol.44 No.4, pp.242-250	view file DOI
2013-01	Surrogate decision-making in Korean patients with advanced cancer: a longitudinal study Lee, June Koo; Keam, Bhumsuk; An, Ah Reum; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Supportive Care in Cancer, Vol.21 No.1, pp.183-190	DOI
2013-02	Comparative analysis of overall survival of patient with non-small cell lung cancer harboring anaplastic lymphoma kinase fusion 이준구	view file
2013-03	Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma Kim, Tae Min; Paeng, Jin Chul; Chun, In Kook; Keam, Bhumsuk; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Lee, Dong Soo; Kim, Chul Woo; Chung, June-Key; Kim, Il Han; Heo, Dae Seog Cancer, Vol.119 No.6, pp.1195-1202	DOI
2013-03	Hypofractionated three-dimensional conformal radiotherapy for medically inoperable early stage non-small-cell lung cancer Lee, Joo Ho; Wu, Hong-Gyun; Kim, Hak jae; Park, Charn Il; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Radiation Oncology Journal, Vol.31 No.1, pp.18-24	view file DOI
2013-04	Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer Kim, Soyeon; Kim, Tae Min; Kim, Dong-Wan; Go, Heounjeong; Keam, Bhumsuk; Lee, Se-Hoon; Ku, Ja-Lok; Chung, Doo Hyun; Heo, Dae Seog Journal of Thoracic Oncology, Vol.8 No.4, pp.415-422	DOI
2013-07	Tumor Burden is Predictive of Survival in Patients With Non-Small-Cell Lung Cancer and With Activating Epidermal Growth Factor Receptor Mutations Who Receive Gefitinib Park, Jin Hyun; Kim, Tae Min; Keam, Bhumsuk; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Tae; Kim, Young Whan; Heo, Dae Seog Clinical Lung Cancer, Vol.14 No.4, pp.383-389	DOI
2013-07	Clinical outcomes of radiation-based locoregional therapy in locally advanced head and neck squamous cell carcinoma patients not responding to induction chemotherapy Lim, Yoojoo; Keam, Bhumsuk; Koh, Youngil; Kim, Tae Min; Lee, Se-Hoon; Hah, J. Hun; Kwon, Tack-Kyun; Kim, Dong-Wan; Wu, Hong-Gyun; Sung, Myung-Whun; Heo, Dae Seog; Kim, Kwang Hyun Oral Surgery Oral Medicine Oral Pathology Oral Radiology, Vol.116 No.1, pp.55-60	DOI
2013-08	Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study Lee, J. K.; Shin, J. -Y.; Kim, S.; Lee, S.; Park, C.; Kim, J. -Y.; Koh, Y.; Keam, B.; Min, H. S.; Kim, T. M.; Jeon, Y. -K.; Kim, D. -W.; Chung, D. H.; Heo, D. S.; Lee, S. -H.; Kim, J. -I. Annals of Oncology, Vol.24 No.8, pp.2080-2087	DOI
2013-08	Erlotinib Versus Gefitinib for Control of Leptomeningeal Carcinomatosis in Non-Small-Cell Lung Cancer Lee, Eunyoung; Keam, Bhumsuk; Kim, Dong-Wan; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Journal of Thoracic Oncology, Vol.8 No.8, pp.1069-1074	DOI
2013-09	How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Cancer Research and Treatment, Vol.45 No.3, pp.178-185	view file DOI
2014-02	Ifosfamide, methotrexate, etoposide, and prednisolone plus L=asparaginase as a first-time therapy in stage III/IV NK/T-cell lumphoma, nasal typr 김미소	view file
2014-03	Clinical Significance of Downstaging in Patients With Limited-Disease Small-Cell Lung Cancer Go, Se-Il; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Hak Jae; Wu, Hong-Gyun; Chung, Doo Hyun; Heo, Dae Seog Clinical Lung Cancer, Vol.15 No.2, pp.E1-E6	DOI
2014-04	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non-Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor A Meta-analysis Lee, June-Koo; Hahn, Seokyung; Kim, Dong-Wan; Suh, Koung Jin; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog JAMA - Journal of the American Medical Association, Vol.311 No.14, pp.1430-1437	DOI
2014-04	Anti-cancer activity of gemcitabine against natural killer cell leukemia/lymphoma Kim, Tae Min; Kim, Soyeon; Ahn, Yong-Oon; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Leukemia and Lymphoma, Vol.55 No.4, pp.940-943	DOI
2014-06	Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer Lee, Yun-Gyoo; Kim, Inho; Lee, Eunyoung; Bang, Soo-Mee; Kang, Chang Hyun; Kim, Young Tae; Kim, Hak Jae; Wu, Hong-Gyun; Kim, Young Whan; Kim, Tae Min; Lee, Keun-Wook; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Thrombosis and Haemostasis, Vol.111 No.6, pp.1112-1120	view file DOI
2014-08	In vitro anticancer activity of phosphatidylinositol 3-kinase alpha selective inhibitor BYL719 in head and neck cancer 김범석	view file
2014-08	Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog International Journal of Clinical Oncology, Vol.19 No.4, pp.594-600	DOI
2014-08	The presence of extrathoracic metastasis is more prognostic of survival than Masaoka stage (IVa/IVb) in metastatic thymic epithelial tumor: A retrospective cohort study Shin, Dong-Yeop; Kim, Dong-Wan; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kang, Chang Hyun; Kim, Young Tae; Heo, Dae Seog Lung Cancer, Vol.85 No.2, pp.320-325	DOI
2014-10	Safety and Efficacy of Dacomitinib in Korean Patients with KRAS Wild-Type Advanced Non-Small-Cell Lung Cancer Refractory to Chemotherapy and Erlotinib or Gefitinib A Phase I/II Trial Park, Keunchil; Cho, Byoung C.; Kim, Dong-Wan; Ahn, Myung-Ju; Lee, Sang-Yoon; Gernhardt, Diana; Taylor, Ian; Campbell, Alicyn K.; Zhang, Hui; Giri, Nagdeep; Letrent, Stephen P.; O'Connell, Joseph; Heo, Dae S. Journal of Thoracic Oncology, Vol.9 No.10, pp.1523-1531	DOI
2014-10	Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Cancer Research and Treatment, Vol.46 No.4, pp.323-330	view file DOI
2014-11	A Phase II Study of Ifosfamide, Methotrexate, Etoposide, and Prednisolone for Previously Untreated Stage I/II Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of the Korean Cancer Study Group Kim, Tae Min; Kim, Dong-Wan; Kang, Yoon-Koo; Chung, Jooseop; Song, Hong-Suk; Kim, Hyo Jung; Kim, Byung Soo; Lee, Jong-Seok; Kim, Hawk; Yang, Sung Hyun; Yuh, Young Jin; Bae, Sung Hwa; Hyun, Myung Soo; Jeon, Yoon Kyung; Kim, Chul Woo; Heo, Dae Seog Oncologist, Vol.19 No.11, pp.1129-1130	DOI
2014-11	International comparison of the factors influencing reimbursement of targeted anti-cancer drugs Lim, Carol Sunghye; Lee, Yun-Gyoo; Koh, Youngil; Heo, Dae Seog BMC Health Services Research, 14(1) : 595	view file DOI
2014-12	Additional prognostic role of EGFR activating mutations in lung adenocarcinoma patients with brain metastasis: Integrating with lung specific GPA score Lee, Dae-Won; Shin, Dong-Yeop; Kim, Jin Wook; Keam, Bhumsuk; Kim, Tae Min; Kim, Hak Jae; Kim, Dong-Wan; Wu, Hong-Gyun; Paek, Sun Ha; Kim, Young Whan; Heo, Dae Seog; Kim, Dong Gyu; Lee, Se-Hoon Lung Cancer, Vol.86 No.3, pp.363-368	DOI
2014-12	The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer Sim, Sung Hoon; Keam, Bhumsuk; Kim, Dong-Wan; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Journal of Cancer Research and Clinical Oncology, Vol.140 No.12, pp.2135-2142	DOI
2015-01	In vitro anticancer activity of PI3K alpha selective inhibitor BYL719 in head and neck cancer Keam, Bhumsuk; Kim, Soyeon; Ahn, Yong-Oon; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Anticancer Research, Vol.35 No.1, pp.175-182
2015-02	상피세포성장인자수용체 돌연변이 폐암에서 insulin-like growth factor-1 발현의 의의 나임일	view file
2015-03	Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL) Kim, Miso; Kim, Tae Min; Kim, Ki Hwan; Keam, Bhumsuk; Lee, Se-Hoon; Kim, Dong-Wan; Lee, Jong Seok; Jeon, Yoon Kyung; Kim, Chul Woo; Heo, Dae Seog Annals of Hematology, Vol.94 No.3, pp.437-444	DOI
2015-04	The impact of molecularly targeted treatment on direct medical costs in patients with advanced non-small cell lung cancer Lee, June-Koo; Kim, Dong-Wan; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Young-Joo; Heo, Dae Seog Cancer Research and Treatment, Vol.47 No.2, pp.182-188	view file DOI
2015-05	Molecular changes associated with acquired resistance to crizotinib in ROS1-rearranged non-small cell lung cancer Song, Ahnah; Kim, Tae Min; Kim, Dong-Wan; Kim, Soyeon; Keam, Bhumsuk; Lee, Se-Hoon; Heo, Dae Seog Clinical Cancer Research, Vol.21 No.10, pp.2379-2387	DOI
2015-06	Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancer Sim, Sung Hoon; Kim, Yu Jung; Kim, Se Hyun; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog; Lee, Jong Seok Journal of Cancer Research and Clinical Oncology, Vol.141 No.6, pp.1073-1081	DOI
2015-07	Neutrophil to lymphocyte ratio improves prognostic prediction of International Prognostic Index for patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone Keam, Bhumsuk; Ha, Hyerim; Kim, Tae Min; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Chul Woo; Heo, Dae Seog Leukemia and Lymphoma, Vol.56 No.7, pp.2032-2038	DOI
2015-08	CD21-independent Epstein-Barr virus entry into NK cells Jeong Hoo Lee	view file
2015-08	Total lesion glycolysis in positron emission tomography can predict gefitinib outcomes in non-small-cell lung cancer with activating EGFR mutation Keam, Bhumsuk; Lee, Soo Jin; Kim, Tae Min; Paeng, Jin Chul; Lee, Se-Hoon; Kim, Dong-Wan; Jeon, Yoon Kyung; Chung, Doo Hyun; Kang, Keon Wook; Chung, June-Key; Heo, Dae Seog Journal of Thoracic Oncology, Vol.10 No.8, pp.1189-1194	DOI

1 2 3 4